Allyson Berent

Allyson Berent

Company: Chief Operating Officer, GeneTx Biotherapeutics

Job title: Chief Scientific Officer, FAST

Seminars:

Live Q&A Session with Your Expert Speakers 6:00 pm

Read more

day: Day One

Angelman Syndrome Biomarker & Outcome Measure Consortium (ABOM): Understanding What Matters to Patients with a Heterogenous Neurodevelopmental Disorder 4:30 pm

• NHS, Disease concept models and focus domains on what is important to patients and caregivers: Staying pre-competitiveRead more

day: Day One

A Journey Through Drug Development for Angelman Syndrome 8:40 am

• Bringing together Passion, Community, Great Science and a Vision is key to success • Support many different therapeutic platforms has value • Supporting NHS and endpoint consortia has served the AS community well in industryRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.